N/ARecruiting
Assessment of CCM in HF With Higher Ejection Fraction
Sponsored by Impulse Dynamics
About this study
The AIM HIGHer Clinical Trial will evaluate the safety and efficacy of Cardiac Contractility Modulation (CCM) therapy in patients with heart failure with LVEF ≥40% and ≤70%.
Enrolling at this location
Pima Heart and Vascular
Tuscon, Arizona
I'm interestedThis study also enrolls at 103 other locations. See all.
Completing a questionnaire on Clinably does not enroll you in a clinical trial or confirm your eligibility. Only the research team can determine whether you qualify to participate. These results are based on the information you provide and are intended to help you start a conversation with the research team.
Trial data sourced from ClinicalTrials.gov.